A Phase Ib Study of the Safety, Reactogenicity, and Immunogenicity of Sm-TSP-2/Alhydrogel)(R) With or Without AP 10-701 for Intestinal Schistosomiasis in Healthy Exposed Adults
Clinical trial NCT03110757 · COMPLETED
Trial details
- NCT number
- NCT03110757
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-20
- Primary completion
- 2019-11-14
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.